RSS Items

Health care-associated infections (HAI) are a significant cause of morbidity and health care costs, affecting over 1 million patients annually. Patient contact has been associated with contamination of health care workers’ hands or clothing and

The Emerging Infections Program (EIP) of the Centers for Disease Control and Prevention (CDC) recently estimated from data collected at designated EIP locations that there were ∼236,000 cases of healthcare-associated Clostridioides difficile

Methicillin-resistant Staphylococcus aureus (MRSA) infections are a source of morbidity and mortality for hospitalized patients. While a universal MRSA decolonization approach is considered more effective than active surveillance and decolonization

Antibiotic overuse puts patients at risk for adverse events and contributes to global antibiotic resistance. More than 2.8 million antibiotic-resistant infections occur in the United States each year, and more than 35,000 people die as a result.1

Antimicrobial stewardship programs (ASP) have been associated with lower in-hospital antimicrobial consumption, earlier discharge when the oral switch protocol is implemented, and lower hospital costs. Nevertheless, their impact on antimicrobial

Hospitalization can be a stressful and emotionally taxing event for patients. Support provided to patients by visitors is recognized as an integral component in addressing the complex needs of hospitalized patients. Patient and family centered care

Clostridioides difficile infection (CDI) is principally healthcare-associated with substantial impact on morbidity and mortality. Guidelines recommend CDI therapy for 10 days; however, it is often extended in practice when concurrent antibiotics are

Over the last fifteen years, the US health care system and its patients have paid an increasingly high price for adverse events. The health care system needs safe and reliable delivery systems to prevent common causes of patient harm.1-4 Health care

Peter JüniMay 25, 2020; 192:E566-E573Research

Clostridioides difficile infection (CDI) is principally health care–associated, with a substantial impact on morbidity and mortality. The guidelines recommend CDI therapy for 10 days; however, it is often extended in practice when concurrent